NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Objective

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

National Clinical Trial (NCT) Number: 05174169

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/ct2/show/NCT05174169

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Oncology Studies

Specialties

• Genitourinary Cancer

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]